MRMiguel Emilio García Rodríguez

Miguel Emilio García Rodríguez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miguel Emilio García Rodríguez has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neurological emergencies in cancer: pathophysiological and prognostic implications with a focus on the elderly

    by Ana Esperanza Jeréz Alvarez, Ariel Sosa Remón, Jhossmar Cristians Auza-Santivañez, Miguel Emilio García Rodríguez, Arian Jesús Cuba Naranjo, Yudiel Pérez Yero, Jorge Márquez-Molina, Freddy Ednildon Bautista-Vanegas

    Introduction: Neurological emergencies in cancer patients are associated with high mortality. This mortality rate is particularly prevalent in the older adult population, for whom limited scientific evidence exists. The objective of this review was to describe the pathophysiological mechanisms and prognosis of the main neurological emergencies that occur in older patients with cancer and lead to their admission to the Intensive Care Unit. To this end, a narrative review of the literature available in databases and search engines such as PubMed, Medline, Scopus, Scielo, and Google Scholar was conducted using the search terms: neuro-oncological emergencies, neurological complications, oncological intensive care, prognostic factors for cancer mortality, and their English translations. The review was conducted between November 2024 and March 2025. Forty-nine references from articles that met the inclusion criteria were used. Among the main results, it is worth highlighting that the main neurological complications described are predominantly metabolic encephalopathy, stroke, status epilepticus, and intracranial hypertension. These factors share mechanistic relationships with neurocritical patients in general, although cancer appears to be a significant factor in their onset and mortality prognosis. This is accompanied by other variables of prognostic interest such as advanced age, cancer stage, individual functional status, hyperglycemia, sepsis, septic shock, and artificial ventilation. It is concluded that pathophysiological and prognostic knowledge of critically ill older neuro-oncology patients is still limited and warrants multiple investigations in their own clinical context. This is because the greatest available evidence corresponds to young adult neurocritical patients without cancer.


  • Open Access

    Prognostic scale for death in critically ill cancer patients due to neurological complications

    by Ariel Sosa Remón, Freddy Ednildon Bautista-Vanegas, Jose Bernardo Antezana-Muñoz, Osman Arteaga Iriarte, Yudiel Pérez-Yero, Arian Jesús Cuba-Naranjo, Miguel Emilio García-Rodríguez, Jhossmar Cristians Auza-Santivañez, Ana Esperanza Jeréz Alvarez, Jaykel Evelio Gómez Triana

    Introduction: The scales used to predict death in cancer patients are scarce and have not been adequately validated in populations with neurological complications. Objective: To design a prognostic scale for death in critically ill cancer patients due to neurological complications. Method: An observational, prospective cohort study was conducted from January 2017 to 2024 in the Oncology Intensive Care Unit of the Institute of Oncology and Radiobiology in Havana, Cuba. The study population consisted of 265 patients. Clinical, oncological, laboratory, and life support variables were studied. Binary logistic regression analysis was used to determine the variables with the best prognostic power for the model. The final variable was mortality in the Intensive Care Unit. Results: The final model consisted of the following variables: ECOG III (OR: 3.62; 95% CI: 1.05 - 12.46; p= 0.041), absence of pupillary reflex (OR: 9.35; 95% CI: 2.24 - 38.99; p= 0.002), intracranial hypertension (OR: 17.91; 95% CI: 3.02 - 105.91; p= 0.001), hyperglycemia (OR: 5.85; 95% CI: 2.07 - 16.49; p= 0.001), hypoxemia (OR: 19.09; 95% CI: 2.91 - 61.67; p= 0.000) and artificial mechanical ventilation (OR: 9.59; 95% CI: 2.59 – 35.51; p = 0.001).Conclusions: The prognostic score classified mortality into 3 risk groups: low (0 to 2 points), moderate (3 to 6 points), and high (7 to 13 points). Mortality was higher in patients with higher scores. Internal validation showed excellent calibration and discrimination.

  • Open Access

    Prurigo nodular como manifestación paraneoplásica de un linfoma hodgkin de localización mediastinal

    by Miguel Emilio García Rodríguez, Miguel Javier García-Basulto, Arián Benavidez Márquez

    Introducción: el prurigo nodular es una dermatosis crónica muy pruriginosa, que se caracteriza por la aparición de nódulos cutáneos hiperqueratósicos en adultos de mediana edad. En ocasiones puede ser la manifestación inicial de una enfermedad linfoproliferativa. Objetivo: presentar el caso de una paciente con antecedentes de prurigo nodular como manifestación paraneoplásica de un linfoma hodgking mediastinal. Presentación del caso: paciente de 48 años de edad con antecedentes de prurigo nodular. A los tres años del diagnóstico presentó un aumento de volumen de la región anterior del tórax. En los estudios imagenológicos se demostró un tumor del mediastino anterosuperior el cual se concluyó en el estudio histológico como un Linfoma Hodgkin variante esclerosis nodular. Conclusiones: las lesiones en piel de curso crónico pueden ser manifestaciones de neoplasias internas.


  • Oligo-Recurrence From a Lung Adenocarcinoma. Usefulness of Resection

    by Miguel Emilio García Rodríguez, Bárbaro Agustín Armas Pérez, Karina Armas Moredo